Digg It - Business

I just got this email inquiry from a prestigious, international hotel chain:

Hello:

I am interested in getting informa

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

tion regarding your seminars, speeches and training programs. Could you please forward me details of some of your r

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

ecent corporate engagements with names and phone numbers of the contact person there for reference purposes.

Thank yo

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

u.

Not bad, right?

It has all of the earmarks of a serious inquiry, one that is ready to award a contract providing th

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

e references check out.

But wait a second.

Before I divulge references, I have found it is essential to know several t

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

hings, especially whether there is a viable deal in the offing.

Here are 5 reasons to NOT divulge references too soon:

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

(1) If you give out the name of the same references too many times, they’ll simply get tired of touting you to other pe

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

ople, no matter how useful you were to them.

(2) The best references are SPECIFIC or as close as possible to possessing

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

the information the inquirer needs. A company interested in negotiation skills training won’t give a hoot about the gre

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

at customer service program you just delivered.

(3) The prospect may not be the qualified buyer, cannot approve your co

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

tract, but can damage your chances of getting it, while abusing the sensibilities of your endorsers. In other words, the

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

re's very little up-side and a big down-side risk.

(4) The prospect might really be favoring the proposal of someone el

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

se who is on the inside track to getting the deal, and they simply want to say they did their due diligence by looking a

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

t a second or third source. You don’t want your references called without a genuine purpose.

(5) It could be a set-up.

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

Your competitor might be using a pal, a shill situated in a good company, to research you, to learn about your clientele

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

, to gather competitive intelligence.

I phoned the email inquirer and determined, within 5 minutes of chat that she had

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

no true need for what we do, there are existing in-house training programs against which we’d be competing, and her man

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

ager didn’t know she was shopping vendors and kicking tires.

As she put it: “I was just trying to think out of the box.

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

”

To abbreviate the story, this inquiry wasn’t worth my time nor the time of my clients.

Toward the end of the call sh

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

e confessed she had only been at her job for about a month.

It was at that point that I nearly asked HER for references

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.diggit.org.ua/article/38265/diggit-5-Reasons-to-Not-Divulge-Client-References-UpFront.html">5 Reasons to Not Divulge Client References Up-Front</a>

BB link (for phorums):
[url=http://www.diggit.org.ua/article/38265/diggit-5-Reasons-to-Not-Divulge-Client-References-UpFront.html]5 Reasons to Not Divulge Client References Up-Front[/url]

You have no doubt heard the saying that the customer is always right. When you are a customer you happy with this position, when you are the owner of a small business, sometimes you see this is like opening Pandora’s box. But for the sake of argument, let me add a caveat to that saying: “The customer is always right, even when they’re wrong and you know it.”

If you purchase a franchise, you are buying licensed rights to carry out the business according to the franchisor's standard methods and received continual support in doing so. A MacDonald's franchise is a prime example of how a franchisee runs a business in the standard way, purchasing the raw material from the franchisor and using the company logo and benefiting from national advertising campaigns.

With all the great four-color printing offers available through the Internet today, it's tempting to take advantage of special offers. But how do you avoid the frustration of rejected pre-press files by printing companies or getting your printing only to see that it did not print as you intended? This article will guide you through the process and help you avoid common pre-press mistakes.

Tags

Links

Digg It - 5 Reasons to Not Divulge Client References Up-Front

Related Articles: